Teva Pharmaceutical Industries Limited ( TEVJF) - Stock Earnings
TEVJF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 29, 2026 AfterMarket | — / — | — | — / — | — |
TEVJF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 433.0 million USD | 4.5 billion USD |
| 2025Q4 | 489.9 million USD | 4.8 billion USD |
| 2026Q1 | 370.0 million USD | 4.0 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TEVJF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -559.0 million USD | 15.8 billion USD |
| 2024 | -1.6 billion USD | 16.5 billion USD |
| 2025 | 1.5 billion USD | 18.7 billion USD |
| 2026 Est. | — | — |
TEVJF
Price: $28.40
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.21 USD
P/E Ratio: 30.58
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 38.4 billion